Jacobs Levy Equity Management »

Acrivon Therapeutics shares owned by Jacobs Levy Equity Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Jacobs Levy Equity Management from 13F filings

Historical chart of Jacobs Levy Equity Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Jacobs Levy Equity Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $227k 46k 4.92